Cohen Milstein Calls on Zenas BioPharma (ZBIO) Investors to Act Following Significant Post-IPO Losses

WASHINGTON, April 22, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC is investigating potential securities fraud claims on behalf of investors in Zenas BioPharma, Inc. (NASDAQ:ZBIO) who acquired shares in the company's September 2024 initial public offering ("IPO"). The firm urges affected investors to contact the firm promptly to discuss their legal rights and recovery options. [Click here for information about joining the class action] Or investors should reach out to Molly J. Bowen, a partne ...